Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Pfizer
Pfizer
Pfizer, GSK named in Onyx buyout gossip
Fierce Biotech
Thu, 12/1/11 - 11:48 am
GSK
Pfizer
M&A
ONYX Pharmaceuticals
Senators Probe Pfizer Plan To Block Generic Lipitor
Pharmalot
Thu, 12/1/11 - 11:28 am
Senate
Pfizer
generics
Lipitor
PBMs
Drugmaker Pfizer completes acquisition of Ferrosan Consumer Health business
Yahoo/AP
Thu, 12/1/11 - 11:25 am
Ferrosan
Pfizer
M&A
Europe
Pfizer Out Of Lipitor's Shadow, But Still Expects To Grow Profits
Seeking Alpha
Thu, 12/1/11 - 11:24 am
Lipitor
generics
Pfizer
Ranbaxy launches Lipitor generic in U.S., shares surge
Yahoo/Reuters
Thu, 12/1/11 - 10:39 am
Lipitor
generics
statins
Pfizer
Ranbaxy
Pfizer and Merck May Benefit From Spinoffs, Goldman Sachs Says
Bloomberg
Wed, 11/30/11 - 02:10 pm
Pfizer
Merck
spinoff
Rivals threaten to take wind from Watson’s generic Lipitor sales
Med City
Wed, 11/30/11 - 11:31 am
Watson
generics
Pfizer
Lipitor
Teva Pharmaceuticals
Ranbaxy
Pfizer After Lipitor to Push Mini-Blockbusters
Bloomberg
Wed, 11/30/11 - 11:29 am
Pfizer
generics
Lipitor
Why There Will Never Be Another Drug Like Lipitor
Forbes
Wed, 11/30/11 - 11:28 am
Pfizer
generics
statins
Lipitor
Forget The Rumors: Why Pfizer Might Be Incentivized To Acquire Lpath Outright
Seeking Alpha
Wed, 11/30/11 - 10:43 am
Lpath
Pfizer
M&A
lipid signaling
Watson Pharma Confirms Launch Of Generic Lipitor
WSJ Online
Wed, 11/30/11 - 09:23 am
Watson
generics
Lipitor
Pfizer
statins
Pfizer aims to keep one-third of Lipitor pie
Reuters
Wed, 11/30/11 - 09:11 am
Pfizer
Lipitor
generics
statins
Ranbaxy Shares Decline Amid Uncertainty Over Lipitor Copy Sales
Bloomberg
Wed, 11/30/11 - 09:10 am
Lipitor
Ranbaxy
generics
statins
Pfizer
Pfizer gets creative to preserve Lipitor's billions in sales as first US generic rivals hit
Yahoo/AP
Tue, 11/29/11 - 06:07 pm
generics
patents
Pfizer
Lipitor
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
Bristol-Pfizer drug gets FDA priority review
Reuters
Tue, 11/29/11 - 08:20 am
Pfizer
FDA
Bristol-Myers Squibb
anticlotting
Eliquis
Pfizer's Xalkori: The Story Can Only Get Better
Seeking Alpha
Mon, 11/28/11 - 04:44 pm
Pfizer
Xalkori
lung cancer
Pfizer's Tanezumab Research Setback Cannot Stop A Strong Investment
Seeking Alpha
Mon, 11/28/11 - 04:32 pm
Pfizer
tanezumab
osteoarthritis
Countdown to Generic Lipitor: Atorvastatin By Any Other Name
WSJ Online
Mon, 11/28/11 - 11:57 am
Lipitor
atorvastatin
Pfizer
generics
statins
Ranbaxy Gains After Report It May Get U.S. Approval for Lipitor
Bloomberg
Sat, 11/26/11 - 10:36 am
Ranbaxy
Lipitor
generics
Pfizer
Pages
« first
‹ previous
…
228
229
230
231
232
233
234
235
236
…
next ›
last »